Dr. Estela Rodriguez

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Dr. Estela Rodriguez

Dec 21, 2024, 07:31 | Insight

Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer

Estela Rodriguez shared a post on X: "This is disappointing. I thought we would have…

Dec 7, 2024, 16:57 | Opinion

Estela Rodriguez: Honoring heroes at FLASCO’s Living with Lung Cancer event

Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of…

Nov 22, 2024, 11:40 | Blog

Estela Rodriguez: The second Lung Cancer Health Equity Summit

Estela Rodriguez shared a post on X: "Hi Y’all! We are PCOM Georgia this morning at…

Nov 2, 2024, 19:25 | Insight

Health Disparities in Cancer Patients Receiving Molecular Testing for Biomarker - Directed Therapy

Estela Rodriguez shared on X: "Health Disparities among Patients with Cancer Who Received Molecular Testing for…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023